The role of exercise prescription in pediatric preventive cardiology programs

Sean D. Connolly*, Kendra M Ward

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.

Original languageEnglish (US)
Pages (from-to)e494-e498
JournalPediatric annals
Volume47
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Preventive Health Services
Cardiology
Prescriptions
Exercise
Pediatrics
Dyslipidemias
Life Style
Obesity
Hypertension
Morbidity
Therapeutics
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{e8551c3d7c4940a7a07646c6cfd18983,
title = "The role of exercise prescription in pediatric preventive cardiology programs",
abstract = "Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.",
author = "Connolly, {Sean D.} and Ward, {Kendra M}",
year = "2018",
month = "12",
day = "1",
doi = "10.3928/19382359-20181114-01",
language = "English (US)",
volume = "47",
pages = "e494--e498",
journal = "Pediatric Annals",
issn = "0090-4481",
publisher = "Slack Incorporated",
number = "12",

}

The role of exercise prescription in pediatric preventive cardiology programs. / Connolly, Sean D.; Ward, Kendra M.

In: Pediatric annals, Vol. 47, No. 12, 01.12.2018, p. e494-e498.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of exercise prescription in pediatric preventive cardiology programs

AU - Connolly, Sean D.

AU - Ward, Kendra M

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.

AB - Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.

UR - http://www.scopus.com/inward/record.url?scp=85058591666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058591666&partnerID=8YFLogxK

U2 - 10.3928/19382359-20181114-01

DO - 10.3928/19382359-20181114-01

M3 - Article

C2 - 30543378

AN - SCOPUS:85058591666

VL - 47

SP - e494-e498

JO - Pediatric Annals

JF - Pediatric Annals

SN - 0090-4481

IS - 12

ER -